Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other

Tags
Quarterly results
Acq. announced
Appointed director

Zomedica Corp. (ZOM) Create: Alert

All | News | Filings
Date FiledTypeDescription
08/10/2023 8-K Quarterly results
Docs: "Zomedica Announces Record Second Quarter 2023 Financial Results: Revenue up 43% to $6.0 Million; Strong 67% Gross Margin & $142.4 Million in Liquidity"
05/11/2023 8-K Quarterly results
Docs: "Zomedica Announces Record First Quarter 2023 Financial Results: Revenue up 45% to $5.5 Million; Strong 70% Gross Margin & $147.5 Million in Liquidity"
05/11/2023 8-K Entry into a Material Definitive Agreement  Interactive Data
Docs: "First Amendment to Multi-Tenant Industrial Triple Net Lease entered into as of May 10, 2023 by and between ULF Northfield Business Center LL and Zomedica Inc"
05/09/2023 8-K Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "Press Release"
03/17/2023 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "Separation Agreement, between Zomedica Inc. and Ann Marie Cotter",
"Offer Letter, between Zomedica Inc. and Peter Donato",
"Zomedica Appoints New Chief Financial Officer ANN ARBOR, MI / ACCESSWIRE / March 17, 2023 / Zomedica Corp . , a veterinary health company offering point-of-care diagnostics and therapeutic products for companion animals, announced that it has appointed Peter L. Donato as its Chief Financial Officer, effective March 16, 2023. Mr. Donato brings over 30 years of public and private company experience in a wide range of finance and business functions primarily in the human health sector, having held a number of senior positions from CFO, President and CEO, Executive Vice President, Senior Vice President, Vice President and Controller. Prior to joining Zomedica, Mr. Donato had a successful consulting practice specializing in public company readiness and was the Chief Financial Officer of Standar..."
03/15/2023 8-K Results of Operations and Financial Condition, Financial Statements and Exhibits  Interactive Data
Docs: "Zomedica Corporation Reports 2022 Results: $18.9 Million Revenue; 72% Gross Margin & $156 Million in Liquidity"
02/09/2023 8-K Results of Operations and Financial Condition, Financial Statements and Exhibits  Interactive Data
Docs: "Zomedica Reports Preliminary Results for the Fourth Quarter and Full Year 2022 ANN ARBOR, MI / ACCESSWIRE / February 9, 2023 / Zomedica Corp. , a veterinary health company offering point-of-care diagnostics and therapeutic products for companion animals, today reported its preliminary unaudited results for the fourth quarter and year ended 2022. Preliminary Fourth Quarter and Full Year 2022 Results:"
11/14/2022 8-K Quarterly results
Docs: "Zomedica Announces Third Quarter 2022 Financial Results: $4.78 Million Revenue; 75% Gross Margin & $158.49 Million in Cash, Cash Equivalents, and Available-for-Sale Securities"
08/24/2022 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "Zomedica Appoints Dr. Pamela Nichols, DVM to Board of Directors ANN ARBOR, MI / ACCESSWIRE / August 23, 2022 / Zomedica Corp. , a veterinary health company offering diagnostic and therapeutic products for companion animals, today announced that Pamela Nichols, DVM has been appointed to its Board of Directors and joining the Audit and Governance committees. Dr. Nichols is the founder of six successful veterinary hospitals and dog boarding/daycare facilities. Her newest hospital is Animal Care Daybreak in South Jordan Utah, which opened in October of 2019. She earned her doctorate in veterinary medicine at Colorado State University in 1996 and her Canine Rehabilitation Practitioner certification in 2004. She has practiced both general medicine and rehabilitation ever since, and recently adde..."
08/15/2022 8-K Quarterly results
07/20/2022 8-K Quarterly results
07/08/2022 8-K Quarterly results
07/08/2022 8-K Quarterly results
06/21/2022 8-K Quarterly results
06/15/2022 8-K Quarterly results
06/09/2022 8-K Quarterly results
05/10/2022 8-K Quarterly results
03/01/2022 8-K Quarterly results
12/10/2021 8-K/A Quarterly results
11/26/2021 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "Confidential Separation Agreement and Release Agreement, between Zomedica Inc. and Bruk Herbst"
11/18/2021 8-K Other Events  Interactive Data
11/12/2021 8-K Quarterly results
Docs: "ADDITIONAL EXHIBITS"
10/04/2021 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "Executive Employment Agreement, among Zomedica Inc., Zomedica Corp. and Larry Heaton",
"Zomedica Appoints Larry Heaton as President and Announces CEO Succession Plan ANN ARBOR, Mich., Oct. 04, 2021 -- Zomedica Corp. , a veterinary health company creating point-of-care diagnostic and therapeutic products for companion animals, today announced that Larry Heaton has been appointed President effective October 1, 2021. Mr. Heaton will assume the role of Chief Executive Officer upon the retirement of current Chief Executive Officer Robert Cohen on October 31, 2021. Following his retirement, Mr. Cohen will remain on the Board of Directors of Zomedica. Mr. Heaton brings to Zomedica more than 35 years of executive leadership and operations experience from the medical device and biotechnology industries with an extensive focus on commercialization and business development in both large..."
10/01/2021 8-K Entry into a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Other Events, Financial State...
Docs: "Stock Purchase Agreement by and between Zomedica Inc. and Branford PVT Mid-Hold, LLC",
"Zomedica Acquires PulseVet ANN ARBOR, Mich., Oct. 01, 2021 -- Zomedica Corp. , a veterinary health company creating point-of-care diagnostic and therapeutic products for companion animals, today announced that it had acquired the Pulse Veterinary Technologies businesses for $70.9 million in an all-cash, stock transaction. Pulse Veterinary Technologies is a world leader in electro-hydraulic shock wave technology for the treatment of a wide variety of conditions in veterinary patients. The high-energy sound waves stimulate cells and release healing growth factors in the body that reduce inflammation, increase blood flow, and accelerate bone and soft tissue development. PulseVet’s technology is used in conditions including tendon and ligament healing, bone healing, osteoarthritis, chronic pai..."
09/13/2021 8-K Quarterly results
08/11/2021 8-K Quarterly results
Docs: "Zomedica Announces Second Quarter 2021 Financial Results TRUFORMA® Instrument Placement Program Implemented to Incentivize Future Assay Sales ANN ARBOR, Mich., Aug. 11, 2021 -- Zomedica Corp. , a veterinary health company creating point-of-care diagnostics products for dogs and cats, today reported consolidated financial results for the three and six months ended June 30, 2021. Amounts, unless specified otherwise, are expressed in U.S. dollars and presented under accounting principles generally accepted in the United States of America . Robert Cohen, Chief Executive Officer of Zomedica stated that, “I fully understand and appreciate that what all of our stakeholders, both internal and external, want to see is continued execution on our goals and the building of increased value in our busin..."
07/30/2021 8-K Submission of Matters to a Vote of Security Holders
05/17/2021 8-K Quarterly results
05/12/2021 8-K Quarterly results
04/21/2021 8-K Quarterly results
03/16/2021 8-K Quarterly results
03/08/2021 8-K Quarterly results
03/04/2021 8-K Quarterly results
02/26/2021 8-K Quarterly results
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy